A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder	Recruiting	Phase 1	2026-01-14		NCT06234423

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
OnCusp Therapeutics, Inc.	1

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dana Farber Cancer Institute	Boston	United States	133
Florida Cancer Specialists	Sarasota	United States	47
Mater Cancer Care Centre	South Brisbane	Australia	2
MD Anderson Cancer Center	Houston	United States	589
Memorial Sloan Kettering Cancer Center	New York	United States	60
Mount Sinai Medical Center	Miami Beach	United States	116
NEXT Oncology	Houston	United States	5
NEXT Oncology	Fairfax	United States	31
NYU Cancer Institute Clinical Cancer Center	New York	United States	1
Sarah Cannon Research Institute at HealthOne	Denver	United States	34
Scri Oncology Partners	Nashville	United States	156
START Midwest	Grand Rapids	United States	79
START San Antonio	San Antonio	United States	30
Stephenson Cancer Center	Oklahoma City	United States	32
Yale University	New Haven	United States	352